The economics of weight loss, with Rebecca Diamond and Claer Barrett
GLP-1 drugs boost women’s odds of landing a job, a new study shows
Read the full articleYou might also wanna read
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
forbes.com·26d ago
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.
mdsc.pe·14d ago
How many Canadian employers are offering GLP-1 coverage for weight loss?
Cost control, eligibility requirements, and health risks of obesity among key factors shaping employer approach to medication: IFEBP survey
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
In this week’s Optimizer, we take a look at how health tech companies are starting to incorporate features ‘built for GLP-1’ users.
theverge.com·1mo ago
GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers
Having been taking a GLP-1, tirzepatide, for about five months, I can share how it impacted me, as the experience is not the same for everyo
bit.ly·1mo agoEffects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
Conditions : Polycystic Ovary Syndrome (PCOS); Obesity; Infertility, Female Interventions : Drug: GLP-1 receptor agonist; Drug: Metformin Sp
Comments
Sign in to join the conversation.
No comments yet. Be the first.